NPC Archive Item: Insulin use may increase mortality in type 2 diabetes

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15 April 2010 A large observational study found a statistically significant association between all-cause mortality and exposure to insulin in people with type 2 diabetes, with nearly a three times […]

NPC Archive Item: Update on glitazones and cardiovascular risks

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 19 March 2010 In a recent Science Advisory, the American Heart Association and the American College of Cardiology Foundation have summarised the currently available data on the cardiovascular risks […]

NPC Archive Item: Statins and risk of diabetes

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 01 March 2010 This meta-analysis found statin therapy was associated with a small increase in the absolute risk of developing diabetes. However, for people in whom statin therapy is […]

NPC Archive Item: Observational study of hypoglycaemic drugs has limitations

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15th January 2010 Compared with metformin monotherapy, the fully adjusted analysis in this UK cohort study found no increased risk of heart failure or myocardial infarction with pioglitazone▼ or […]

NPC Archive Item: Study of insulin detemir should not deflect from NICE guidance

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 November 2009 This open label randomised trial suggests that using insulin detemir in people with type 2 diabetes leads to similar median HbA1c levels as twice daily biphasic […]